Tag Archive for: GMP

Micrograph captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland © NIH

Vaccine maker Sumagen Co. Ltd has launched a  cGMP manufacturing partnership with French Naobios SAS for clinical testing of Sumagen’s inactivated HIV vaccine candidate.
 

Richter-Helm´s expanded manufacturing site at Bovenau, Germany  ready to manufacture your product; ©Richter-Helm

Professionalism and quality are always at the forefront along the whole value chain: from gene to product. To pro-actively meet the evolving demand of the market to produce new assets Richter-Helm significantly increased its manufacturing capacities for biopharmaceutical products at its production site in Bovenau, Germany.

Figure 1: Example of a process landscape; © Richter-Helm BioLogics GmbH & Co.KG

The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These growing structures often expose vulnerabilities and challenges for the business. Therefore, companies need to increase the stability and efficiency of their processes.

Picture: © Northway Biotech

When businesses receive a proposal from a contract development and manufacturing organisation (CDMO), it’s much like a first date: first impressions matter. The proposal process not only reveals a CDMO’s services but also hints at the potential relationship’s quality. This is gauged mainly through metrics like timing, quality, and price.

Cancer cell © peterschreiber. media - stock.ado

CDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences.